Last updated on January 2020

Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer


Find a site near you

Start Over

Research Site

Kawagoe-shi, Japan
2.0miles
  Connect »